Is Medical Properties Trust (MPT) Pricing Reflect Its Repositioning And Recent Share Price Recovery

Medical Properties Trust, Inc. -0.22%

Medical Properties Trust, Inc.

MPT

4.63

-0.22%

  • If you are looking at Medical Properties Trust and wondering whether the current share price reflects its underlying worth, you are not alone.
  • The stock closed at US$5.65 recently, with returns of 12.5% over the last 30 days, 11.2% year to date and 4.4% over the past year, set against longer term 3 year and 5 year returns of 28.9% and 60.3% declines.
  • Recent headlines around Medical Properties Trust have focused on its balance sheet, portfolio repositioning and how it is responding to a tougher backdrop for real estate investment trusts. Together, these help explain some of the shorter term share price swings. For you as an investor, that news context matters because it can affect how the market is thinking about risk and required returns for the stock.
  • On Simply Wall St's valuation framework, Medical Properties Trust scores a 5 out of 6 for being undervalued across key checks. This sets up a closer look at how different valuation approaches stack up here and hints at an even richer way to think about value that we will come back to at the end.

Approach 1: Medical Properties Trust Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model estimates what a business could be worth today by projecting its future adjusted funds from operations and discounting those cash flows back to a present value.

For Medical Properties Trust, the model uses last twelve month free cash flow of about $183.9 million and a 2 Stage Free Cash Flow to Equity approach based on adjusted funds from operations. Analysts provide free cash flow estimates out to 2030, with Simply Wall St extending the projections out to 2035. By 2030, projected free cash flow is $413 million, with each future year discounted back into today’s dollars and summed.

On this basis, the estimated intrinsic value comes out at about $7.74 per share, compared with the recent share price of $5.65. That implies the shares trade at roughly a 27.0% discount to this DCF estimate. On this model the stock screens as undervalued rather than fully priced.

Result: UNDERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Medical Properties Trust is undervalued by 27.0%. Track this in your watchlist or portfolio, or discover 45 more high quality undervalued stocks.

MPT Discounted Cash Flow as at Mar 2026
MPT Discounted Cash Flow as at Mar 2026

Approach 2: Medical Properties Trust Price vs Sales

For many profitable and revenue generating companies, the P/S ratio is a useful way to see what investors are paying for each dollar of sales, especially when earnings can be affected by non cash items or one off factors.

What counts as a normal or fair P/S ratio usually reflects how the market views a company’s growth prospects and risk profile. Higher expected growth and lower perceived risk tend to support higher multiples, while slower growth or higher uncertainty usually mean a lower P/S looks more appropriate.

Medical Properties Trust currently trades on a P/S of 3.16x. That is below the Health Care REITs industry average P/S of 7.01x and also below the peer group average of 7.71x. Simply Wall St’s Fair Ratio for Medical Properties Trust is 6.18x, which is the P/S level its model suggests based on factors such as earnings growth, industry, profit margin, market cap and company specific risks.

The Fair Ratio is more tailored than simple peer or industry comparisons because it adjusts for the company’s own growth profile, risk and profitability rather than assuming it should trade in line with the group. With the current 3.16x P/S sitting well below the 6.18x Fair Ratio, the shares screen as undervalued on this metric.

Result: UNDERVALUED

NYSE:MPT P/S Ratio as at Mar 2026
NYSE:MPT P/S Ratio as at Mar 2026

P/S ratios tell one story, but what if the real opportunity lies elsewhere? Start investing in legacies, not executives. Discover our 19 top founder-led companies.

Upgrade Your Decision Making: Choose your Medical Properties Trust Narrative

Earlier we mentioned that there is an even better way to understand valuation, so let us introduce you to Narratives, which are simply your story about Medical Properties Trust tied directly to a set of numbers. Narratives link what you think about its tenants, balance sheet and hospital exposure to a forecast for revenue, earnings, margins and finally a fair value estimate.

On Simply Wall St’s Community page, Narratives are presented as easy to use, living valuation stories that update when new news or earnings arrive. They help you compare your own fair value to the current share price and decide whether the stock looks expensive or cheap against your assumptions.

For Medical Properties Trust, for example, one published Narrative anchors on a higher fair value of US$8.00 per share with relatively higher future margins and a richer future P/E. Another uses a lower fair value of US$4.50 with more cautious assumptions for growth and profitability. Your job as an investor is to see which story and set of numbers feels closer to how you think the business will actually perform.

For Medical Properties Trust however we will make it really easy for you with previews of two leading Medical Properties Trust Narratives:

Fair value in this bullish narrative: US$8.00 per share

Gap to fair value: about 29% below that US$8.00 anchor based on the recent US$5.65 share price

Revenue growth assumption: 2.54% a year

  • Analysts in this camp see Medical Properties Trust using its access to capital and rent growth to support higher earnings and cash flow over time.
  • The model combines steady revenue growth and improved profit margins with a higher future P/E multiple to arrive at a US$8.00 fair value.
  • Key risks they highlight include higher borrowing costs, tenant concentration and potential pressure on hospital real estate values.

Fair value in this bearish narrative: US$4.50 per share

Gap to fair value: about 26% above that US$4.50 anchor based on the recent US$5.65 share price

Revenue growth assumption: 1.23% a year

  • Analysts in this camp focus on tenant concentration, refinancing costs and hospital demand trends as constraints on future cash flow resilience.
  • Their US$4.50 fair value reflects more cautious assumptions for margins and the P/E multiple they think the market may be willing to pay.
  • They still factor in some improvement in earnings from today, but see the current price as leaving less room for setbacks in rent collection or asset values.

If you want to see how other investors are joining the discussion and building on these stories, Curious how numbers become stories that shape markets? Explore Community Narratives can give you a wider range of views to compare with your own expectations.

Do you think there's more to the story for Medical Properties Trust? Head over to our Community to see what others are saying!

NYSE:MPT 1-Year Stock Price Chart
NYSE:MPT 1-Year Stock Price Chart

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.